ConvaTec
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, ConvaTec sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).
ConvaTec: 17 sponsored US clinical trials, 3 recruiting.
ConvaTec sponsors 17 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 12 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Wound Heal, with 4 trials.
Top-decile sponsor footprint
ConvaTec ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
12 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
17 total, page 1 of 1
EDX110 Randomized Control Trial for Treatment of DFUs
NCT07209358
IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
NCT06616844
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
NCT06606210
Observational Study to Investigate the Use of Sterilized Porcine Placental Tissue in the Treatment of Chronic VLU
NCT06400875
Sterilised, Porcine Placental Tissue in the Treatment of Chronic Diabetic Foot Ulcers
NCT05687656
A Retrospective, Observational Study of the Real-world Safety and Performance of InnovaMatrix® AC at a Single Centre
NCT07170566
A Prospective, Multi Centre, Interventional, Non-comparator, Open Label Study to Demonstrate the Efficacy, Performance and Safety of ConvaFoam™ Silicone, ConvaFoam™ Border and ConvaFoam™ Non-Adhesive Dressings in the Management of Surgical and Traumatic Wounds
NCT05632276
A Prospective, Multi Centre, Interventional, Non-comparator, Open Label Study to Demonstrate the Efficacy, Safety, and Performance of ConvaFoam™ Dressings in the Management of Indicated Chronic Wound Types.
NCT05632250
GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology
NCT05470751
Assessment of Novel Technology to Facilitate Drainage in Ostomy Pouches: OUTFLOW Study
NCT06394115
One Piece Closed Pouch in Subjects With a Colostomy
NCT01935999
One Piece Drainable Pouch in Subjects With an Ileostomy
NCT01939106
Comparison Study of 3 Ostomy Products
NCT01691729
Assess the Safety and Adhesive Performance of the VIPER System When Compared to Esteem™
NCT01261988
Vitala 12 Hour Wear Test With Convex Products
NCT01138709
Multi-National Phase III Vitala™ 12-Hour Wear Test
NCT00902252
Comparative Evaluation of Two AQUACEL Ag Protocols of Care for the Management of Donor Sites
NCT00731367
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 2 |
Therapeutic Areas
What is open in the ConvaTec pipeline
3 recruiting of 17 indexed (18% open); 12 completed (71%).
Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Wound Heal (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
ConvaTec: open-pipeline peers nationwide
Peers matched on 17 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
ConvaTec sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 17 trials (± recruiting share)
- Achieve Life Sciences · 17 trials · 0% recruiting
- BioDelivery Sciences International · 17 trials · 6% recruiting
- Chugai Pharmaceutical · 17 trials · 24% recruiting
- Durham VA Medical Center · 17 trials · 6% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
- Sanford Health · 18% recruiting · 34 trials
Related
What to do with this ConvaTec page
17 registered trials is a research-attention snapshot, not an endorsement of ConvaTec or any single study.
- 3 of ConvaTec's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Wound Heal is the condition ConvaTec studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Wound Heal trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
ConvaTec pipeline card: 17 registered trials from official public datasets.Report a data error.